Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta-Analysis of Randomized Controlled Trials.

导出 OA

翻译打印收藏纠错

作者： Jawad,Basit ^[1] ; Mushood,Ahmed ^[2] ; Aimen,Shafiq ^[1] ; Zaofashan,Zaheer ^[3] ; Abdulqadir J,Nashwan ^[4] ; Aleena,Ahmed ^[5] ; Mohammad,Hamza ^[4] ; Usman,Naseer ^[6] ; Shafaqat,Ali ^[7] ; Neelesh,Gupta ^[8] ; Yasar,Sattar ^[9] ; Akram,Kawsara ^[10] ; Ramesh,Daggubati ^[10] ; M Chadi,Alraies ^[10]

作者单位： Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan. ^[1] Cardiovascular Analytics Group, Canterbury, UK. ^[2] Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan. ^[3] Department of Medicine, King Edward Medical University, Lahore, Pakistan. ^[4] Hamad Medical Corporation, Doha, Qatar. ^[5] Guthrie Medical Group, Cortland, New York, USA. ^[6] Department of Cardiology, USD Sanford School of Medicine, Sioux Falls, South Dakota, USA. ^[7] Department of Internal Medicine, Louisiana State University, Shreveport, Louisiana, USA. ^[8] Department of Cardiology, Kirk Kerkorian School of Medicine, University of Nevada Las Vegas, Las Vegas, Nevada, USA. ^[9] Department of Interventional Cardiology, West Virginia University, Morgantown, West Virginia, USA. ^[10] Department of Cardiology, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA. ^[11]

关键词 Everolimus‐eluting stents (EES)Zotarolimus‐eluting stents (ZES)major adverse cardiovascular events (MACE)meta‐analysis randomized controlled trials target vessel myocardial infarction (TVMI)